These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28559437)

  • 1. Fibroblast growth factor 21: a regulator of metabolic disease and health span.
    Xie T; Leung PS
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E292-E302. PubMed ID: 28559437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of fibroblast growth factor 21 in the brain.
    Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.
    So WY; Leung PS
    Med Res Rev; 2016 Jul; 36(4):672-704. PubMed ID: 27031294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus.
    Dostálová I; Haluzíková D; Haluzík M
    Physiol Res; 2009; 58(1):1-7. PubMed ID: 19331512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.
    Ding X; Boney-Montoya J; Owen BM; Bookout AL; Coate KC; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2012 Sep; 16(3):387-93. PubMed ID: 22958921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF21 in obesity and cancer: New insights.
    Lu W; Li X; Luo Y
    Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of FGF21 on glycemic control.
    Strowski MZ
    Horm Mol Biol Clin Investig; 2017 Jun; 30(2):. PubMed ID: 28593912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
    Owen BM; Mangelsdorf DJ; Kliewer SA
    Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
    Kruse R; Vienberg SG; Vind BF; Andersen B; Højlund K
    Diabetologia; 2017 Oct; 60(10):2042-2051. PubMed ID: 28721439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.
    Martínez-Garza Ú; Torres-Oteros D; Yarritu-Gallego A; Marrero PF; Haro D; Relat J
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.
    Stanislaus S; Hecht R; Yie J; Hager T; Hall M; Spahr C; Wang W; Weiszmann J; Li Y; Deng L; Winters D; Smith S; Zhou L; Li Y; Véniant MM; Xu J
    Endocrinology; 2017 May; 158(5):1314-1327. PubMed ID: 28324011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-klotho in type 2 diabetes mellitus: From pathophysiology to therapeutic strategies.
    Hua S; Liu Q; Li J; Fan M; Yan K; Ye D
    Rev Endocr Metab Disord; 2021 Dec; 22(4):1091-1109. PubMed ID: 34120289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
    Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
    Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review.
    Yuan D; Wu BJ; Henry A; Rye KA; Ong KL
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):47-55. PubMed ID: 30346647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.